Annual Cash & Cash Equivalents
$63.23 M
+$29.55 M+87.72%
31 December 2023
Summary:
Pliant Therapeutics annual cash & cash equivalents is currently $63.23 million, with the most recent change of +$29.55 million (+87.72%) on 31 December 2023. During the last 3 years, it has risen by +$11.57 million (+22.39%). PLRX annual cash & cash equivalents is now -26.31% below its all-time high of $85.81 million, reached on 31 December 2019.PLRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$79.62 M
-$770.00 K-0.96%
30 September 2024
Summary:
Pliant Therapeutics quarterly cash and cash equivalents is currently $79.62 million, with the most recent change of -$770.00 thousand (-0.96%) on 30 September 2024. Over the past year, it has increased by +$16.38 million (+25.91%). PLRX quarterly cash and cash equivalents is now -55.39% below its all-time high of $178.46 million, reached on 30 June 2020.PLRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLRX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +25.9% |
| 3 y3 years | +22.4% | +54.1% |
| 5 y5 years | -26.3% | -7.2% |
PLRX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +87.7% | -30.3% | +217.6% |
| 5 y | 5 years | -26.3% | +87.7% | -55.4% | +217.6% |
| alltime | all time | -26.3% | +87.7% | -55.4% | +354.1% |
Pliant Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $79.62 M(-1.0%) |
| June 2024 | - | $80.39 M(-29.7%) |
| Mar 2024 | - | $114.30 M(+80.8%) |
| Dec 2023 | $63.23 M(+87.7%) | $63.23 M(+9.6%) |
| Sept 2023 | - | $57.68 M(+5.0%) |
| June 2023 | - | $54.95 M(-46.4%) |
| Mar 2023 | - | $102.53 M(+204.4%) |
| Dec 2022 | $33.69 M(-34.8%) | $33.69 M(-24.5%) |
| Sept 2022 | - | $44.62 M(+78.0%) |
| June 2022 | - | $25.07 M(-23.0%) |
| Mar 2022 | - | $32.55 M(-37.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $51.66 M(+1.5%) | $51.66 M(+14.2%) |
| Sept 2021 | - | $45.23 M(+28.5%) |
| June 2021 | - | $35.19 M(-30.7%) |
| Mar 2021 | - | $50.82 M(-0.1%) |
| Dec 2020 | $50.88 M(-40.7%) | $50.88 M(-7.9%) |
| Sept 2020 | - | $55.22 M(-69.1%) |
| June 2020 | - | $178.46 M(+57.4%) |
| Mar 2020 | - | $113.37 M(+32.1%) |
| Dec 2019 | $85.81 M(+40.8%) | $85.81 M(+323.3%) |
| June 2019 | - | $20.27 M(+15.6%) |
| Dec 2018 | $60.95 M | - |
| Dec 2018 | - | $17.53 M |
FAQ
- What is Pliant Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Pliant Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of PLRX is $63.23 M
What is the all time high annual cash & cash equivalents for Pliant Therapeutics?
Pliant Therapeutics all-time high annual cash & cash equivalents is $85.81 M
What is Pliant Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of PLRX is $79.62 M
What is the all time high quarterly cash and cash equivalents for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly cash and cash equivalents is $178.46 M
What is Pliant Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, PLRX quarterly cash and cash equivalents has changed by +$16.38 M (+25.91%)